ABBOTINDIAAbbott India Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹28,275.00
▲ 0.78%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)60,082.40
P/E38.76
P/B12.59
PEG5.10
ROE %34.46
ROCE %36.70
Debt / Equity0.04
EPS729.43
Revenue Growth %6.50
Profit Growth %7.60
Dividend Yield %1.68
Promoter Holding %75.55
FII Holding %7.91
DII Holding %—
Beta0.02
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Bull Flag | LONG | 64% | ₹28,275.00 | ₹27,365.00 | ₹30,620.00 | 2.58 |
HOLDConviction 78%
The picture
- • ROE: 34.5%
- • ROCE: 36.7%
- • Debt/Equity: 0.04
- • RSI: 73
- • MACD: bullish
- • Price vs EMA21: above
- • Bull Flag signal (setup quality 64%)
Bull case
- • ROE: 34.5%
- • ROCE: 36.7%
- • Debt/Equity: 0.04
- • RSI: 73
Bear case
- • Revenue growth: 6.5% YoY
- • Profit growth: 7.6% YoY
- • Golden cross setup: SMA50 below SMA200
- • Volume: 0.6x 20-day average
Key risks
- • Revenue growth: 6.5% YoY
- • Profit growth: 7.6% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹28,275.00
Stop Loss
₹27,009.30
risk 4.5%
Target 1 (1.5R)
₹30,173.55
+6.7%
Target 2 (3R)
₹32,072.09
+13.4%
Support (20d)
₹25,200.00
Resistance (52w)
₹35,310.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹1,265.70/share
ATR (volatility)
₹506.28
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹506.28). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
67
Technical
67
Momentum
67
Risk (safety)
68